NCT03710876 2026-04-21
INFINITE
Ferring Ventures Limited
Phase 3 Completed
Ferring Ventures Limited
Bristol-Myers Squibb
Novartis
Novartis
University of Chicago
Akeso
Abramson Cancer Center at Penn Medicine
National Cancer Institute (NCI)
Fundación GECP
Syndax Pharmaceuticals